Skip to product information
1 of 1

DGCR8 Mouse mAb

DGCR8 Mouse mAb

Catalog Number: S0B60224 Application: WB, IP Reactivity: Hu, Ms, Rt Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen DGCR8
Synonyms Microprocessor complex subunit DGCR8; C22orf12; DGCRK6
Location Nucleus
Accession Q8WYQ5
Antibody Type Mouse mAb
Isotype IgG2a
Application WB, IP
Reactivity Hu, Ms, Rt
Positive Sample K562, Jurkat, HEK-293, RAW264.7, rat brain
Purification Protein A
Concentration 1.6 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:500-1:5000 Hu, Ms, Rt
IP 1:50 Hu, Ms, Rt

Background

DGCR8 (DiGeorge Syndrome Critical Region 8), also known as Pasha in invertebrates, is an essential double-stranded RNA-binding protein that functions as a core component of the Microprocessor complex alongside the RNase III enzyme Drosha, playing a pivotal role in the canonical biogenesis of microRNAs (miRNAs) within the nucleus. By recognizing and binding to the apical loop and single-stranded RNA segments of primary miRNA transcripts (pri-miRNAs), DGCR8 serves as a molecular ruler that positions Drosha to precisely cleave the pri-miRNA base, thereby generating precursor miRNAs (pre-miRNAs) that are subsequently exported to the cytoplasm for further processing into mature miRNAs involved in post-transcriptional gene regulation. Beyond its central function in miRNA processing, DGCR8 contributes to the maintenance of genomic stability, DNA damage response, and cellular differentiation, and its haploinsufficiency due to deletions in chromosome 22q11.2 is directly linked to DiGeorge syndrome (22q11.2 deletion syndrome), a multisystem developmental disorder characterized by congenital heart defects, immune deficiencies, and neuropsychiatric abnormalities, underscoring the critical importance of precise DGCR8-mediated regulatory networks in human development and disease.

Picture

Western Blot

WB result of DGCR8 Mouse mAb
Primary antibody: DGCR8 Mouse mAb at 1/500 dilution
Lane 1: K-562 whole cell lysate 20 µg
Lane 2: Jurkat whole cell lysate 20 µg
Lane 3: HEK-293 whole cell lysate 20 µg
Secondary antibody: Goat Anti-Mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 86 kDa
Observed MW: 115 kDa

WB result of DGCR8 Mouse mAb
Primary antibody: DGCR8 Mouse mAb at 1/500 dilution
Lane 1: Raw 264.7 whole cell lysate 20 µg
Secondary antibody: Goat Anti-Mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 86 kDa
Observed MW: 120 kDa

WB result of DGCR8 Mouse mAb
Primary antibody: DGCR8 Mouse mAb at 1/500 dilution
Lane 1: rat brain lysate 20 µg
Secondary antibody: Goat Anti-Mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 86 kDa
Observed MW: 120 kDa